Ippei Fukada Selected Research

Ippei Fukada Research Topics

Disease

20	Breast Neoplasms (Breast Cancer) 05/2022 - 11/2014
10	Neoplasms (Cancer) 05/2022 - 01/2013
5	Neoplasm Metastasis (Metastasis) 10/2018 - 10/2009
2	Pulmonary Hypertension 01/2016 - 04/2015
2	Thrombotic Microangiopathies 01/2016 - 04/2015
1	Neutropenia 10/2017
1	Macular Edema 05/2017
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2017
1	Hypoxia (Hypoxemia) 01/2016
1	Dyspnea (Shortness of Breath) 01/2016
1	Fatty Liver 01/2016
1	Liver Diseases (Liver Disease) 01/2016
1	Disease Progression 12/2015
1	Adenocarcinoma 01/2015
1	Scirrhous Adenocarcinoma (Scirrhous Carcinoma) 01/2015
1	Clear Cell Sarcoma 01/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2009

Drug/Important Bio-Agent (IBA)

5	Trastuzumab (Herceptin)FDA Link 01/2022 - 12/2015
5	eribulin FDA Link 12/2021 - 01/2016
5	taxaneIBA 12/2021 - 01/2015
4	ErbB Receptors (EGF Receptor)IBA 05/2022 - 11/2014
4	Hormones (Hormone)IBA 01/2022 - 07/2016
4	AnthracyclinesIBA 12/2021 - 01/2015
4	Capecitabine (Xeloda)FDA Link 01/2016 - 11/2014
3	Phenobarbital (Luminal)FDA Link 01/2018 - 01/2016
2	Circulating Tumor DNAIBA 05/2022 - 04/2020
2	Fulvestrant (Faslodex)FDA Link 01/2022 - 07/2016
2	human ERBB2 proteinIBA 01/2022 - 10/2018
2	Taxoids (Taxanes)IBA 12/2021 - 07/2016
2	pertuzumabIBA 10/2018 - 10/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2017 - 01/2017
2	thiamine triphosphorate (TTP)IBA 07/2016 - 07/2016
2	Imatinib Mesylate (Gleevec)FDA Link 01/2016 - 04/2015
2	Lapatinib (GW572016)FDA Link 12/2015 - 11/2014
1	Cyclin-Dependent Kinase 4IBA 05/2022
1	AntigensIBA 05/2022
1	Tumor Biomarkers (Tumor Markers)IBA 05/2022
1	Carcinoembryonic AntigenIBA 05/2022
1	Estrogen ReceptorsIBA 05/2022
1	Cell-Free Nucleic AcidsIBA 04/2020
1	130-nm albumin-bound paclitaxelIBA 10/2018
1	Pharmaceutical PreparationsIBA 05/2017
1	Retinaldehyde (Retinal)IBA 05/2017
1	Bevacizumab (Avastin)FDA Link 05/2017
1	Aromatase InhibitorsIBA 07/2016
1	Therapeutic UsesIBA 07/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Tyrosine Kinase InhibitorsIBA 01/2016
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2016
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2015
1	Methotrexate (Mexate)FDA LinkGeneric 01/2015
1	4-azidobenzylcarazolol (pABC)IBA 01/2015
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2015
1	MART-1 AntigenIBA 01/2013
1	Melanins (Melanin)IBA 01/2013
1	Gemcitabine FDA Link 10/2009

Therapy/Procedure

8	Therapeutics 05/2022 - 02/2015
7	Drug Therapy (Chemotherapy) 10/2018 - 10/2009
4	Neoadjuvant Therapy 12/2021 - 01/2016
2	Segmental Mastectomy (Lumpectomy) 05/2017 - 01/2015
1	Drug Tapering 10/2017
1	Lymph Node Excision (Lymph Node Dissection) 05/2017
1	Time-to-Treatment 01/2017
1	Combination Drug Therapy (Combination Chemotherapy) 01/2015
1	Aftercare (After-Treatment) 01/2015